Title: Acylating agents as enzyme inhibitors and understanding their reactivity for drug design.
Journal: Journal of medicinal chemistry 20020620
13947-21-2
50978-45-5
15448-99-4
81-07-2
128-44-9
52188-11-1
1374247-40-1 | potassium (3-acetamidophenyl)trifluoroboranuide | AA00J0G5 | MFCD09993542
70459-02-8 | 1-ethyl-6-fluoro-4-oxo-7-(piperidin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid | AA00J0K3 | MFCD01471127
1381260-70-3 | 6,7-dimethoxy-3-{[(4-methoxyphenyl)amino]methyl}-1,2-dihydroquinolin-2-one | AA00J0MZ | MFCD22684479
1071550-46-3 | [2-(1H-pyrazol-1-yl)ethyl]amine dihydrochloride | AA00J0QY | MFCD06801243
1177296-42-2 | 2-(1-adamantyl)pyrrolidine hydrochloride | AA00J0U1 | MFCD07375389
1083368-48-2 | 1-(4,6-dimethylpyridin-2-yl)-N-methylmethanamine | AA00J0X9 | MFCD15204355
1309668-18-5 | Rac-(2s,6s)-2,6-diallyl-4-methyl-1,2,3,6-tetrahydropyridine | AA00J10I | MFCD01202924
1262770-98-8 | (2,1,3-benzoxadiazol-5-ylmethyl)methylamine hydrochloride | AA00J13C | MFCD13193874
89677-01-0 | 4-(3-aminopropyl)-1,3-thiazol-2-amine dihydrochloride | AA00J15G | MFCD13186149
1255717-05-5 | [1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]amine trifluoroacetate | AA00J192 | MFCD13193929